Home›Companies›Biotech & Pharma›Bio Usawa

Bio Usawa Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 27, 2026·Suggest an edit

About Bio Usawa

Bio Usawa is a private company based in San Francisco, California, incorporated in 2023 in Delaware. It has reported $2,608,900 raised in three offerings on Form D since December 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 30, 2025Dec 17, 2025amended Jan 27, 2026$500,000target not set7$71,429EquityRule 506(b)Form D/A ↗1 earlier filing
Feb 21, 2024Dec 17, 2025$1,705,000fully sold25$68,200EquityRule 506(b)Form D ↗
Jan 16, 2025Dec 17, 2025$403,900fully sold5$80,780EquityRule 506(b)Form D ↗
Total, three offerings$2,608,900

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Bio Usawa's Form D filed Jan 27, 2026.

Richard Chin
Richard Chin
Director
Also a co-founder, chair of the board at VETmAb BIO.
JH
John Hautman
Chief Legal Officer
MB
Menghis Bairu
Executive officer and director

Sources

  1. SECBio Usawa Inc. Form D, filed Dec 17, 2025
  2. SECBio Usawa Inc. filing history